Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 16571-783

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 16571-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

Rising Pharma Holdings, Inc's Cyclobenzaprine Hydrochloride USP 5mg Tablets are distributed in India under the code PRising NG 16571.782.01 S. They come in a package containing 100 tablets and are meant to be stored at temperatures between 20° to 25°C (88° to 7T°F). The tablets are not intended for use without proper consultation with a doctor. The overprinting zone coding area (4515 mm) is present on the package and dotted lines in that area should not be printed.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

Each film-coated tablet of Cyclobenzaprine Hydrochloride USP 10mg is contained in a package distributed by Rising Pharma Holdings, Inc. It is recommended for adults to take one tablet per day, and the product should be stored at a temperature between 20°C to 25°C. The provided information is not intended for tablets outside of the USP package.*

FDA Label Image

Chemical Structure (Cyclobenz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.